Nipro looks to cost benefits and new markets as it sets up pharma shop in Vietnam
This article was originally published in Scrip
Executive Summary
The pharmaceutical division of Nipro Corp has confirmed to Scrip that it is to make an initial investment of ¥6 billion ($78 million) in a new facility for the production of generic drugs in Vietnam.
You may also be interested in...
Quick Listen: Scrip’s Five Must-Know Things
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.
Catchup Capsule: Key APAC Insights You Need To Read
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Catchup Capsule: Key APAC Insights You Need To Read
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Need a specific report? 1000+ reports available
Buy Reports